Role of procalcitonin in viral and bacterial meningitis
DOI:
https://doi.org/10.18203/2349-3933.ijam20212406Keywords:
Meningitis, Procalcitonin, Cerebrospinal fluid, C-reactive proteinAbstract
Background: Meningitis is one of the most common central nervous system infections by bacteria, virus or fungus encountered in infants and children.Early diagnosis of meningitis and differentiation of bacterial from non-bacterial/ viral meningitis tends to play an important role in the emergency management of children with suspected meningitis. While cerebrospinal fluid analysis is popular, along with biomarkers: C-reactive protein and white blood cell count, serum procalcitonin seems to offer an even better specificity.
Methods: A hospital based cross-sectional-study was conducted in department of neurology in collaboration with department of pathology, Medanta, Medicity, Gurugram, for a period of one year from March 2018 to 2019. 100 children aged 4 months to 12 years, with suspected meningitis were enrolled. The study group was further subdivided into two groups, based upon their bacteriological profile: bacterial meningitis and viral meningitis.
Results: For both the groups, the common clinical presentations were fever (100% and 96.88%), convulsions (58.33% and 45.31%), vomiting (25% and 43.75%), The demographic and clinical profile of the 2 groups was largely comparable. Serum PCT levels were significantly higher in bacterial meningitis group compared to non-bacterial meningitis with p<0.001. The sensitivity of serum PCT was found to be 97% and superior to CRP in terms of accuracy in identification and to assess the severity. Procalcitonin is an ideal marker with highest accuracy for bacterial infections.
Conclusions: Serum PCT can act as a more sensitive and specific diagnostic tool in early differentiation of bacterial from non-bacterial meningitis in children.
References
Holmquist L, Russo CA, Elixhauser A. Meningitis-related hospitalizations in the united states, 2006: statistical brief #57. In: healthcare cost and utilization project (HCUP) Statistical Briefs. USA: Agency of health Care Research; 2008.
Hrishi AP, Sethuraman M. Cerebrospinal fluid analysis and interpretation in neurocritical care for acute neurological conditions. Indian J Crit Care Med. 2019; 23(Suppl 2):S115-9.
Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections--hope for hype?. Swiss Med Wkly. 2009;139(23):318-26.
Liliana S, France G, Devendra KA, Patrick S-L, Jacques L, Serum Procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-17.
Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;20: 1-9.
Vikse J, Henry BM, Roy J, Ramakrishnan PK, Tomaszewski KA, Walocha JA. The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis. Int J Infect Dis. 2015;38:68-76.
Mills GD, Lala HM, Oehley MR, Craig AB, Barratt K, Hood D, et al. Elevated procalcitonin as a diagnostic marker in meningiococcal disease. Eur J Clin Microbiol Infect Dis. 2006;25:501-9.
Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997;24(6):1240-2.
Abdel-Wahab AA, Ibrahim AS. Diagnostic value of serum procalcitonin levels in children with meningitis: a comparison with blood leukocyte count and C-reactive protein. J Pak Med Assoc. 2011; 61(4):346-51.
Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis. 2002; 186(Suppl 2):S225-33.
Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, et al. Serum Procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children. Arch Pediatr Adolesc Med. 2008;162(12):1157.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-8.
Chaudhary S, Bhatta NK, Lamsal M, Chaudhari RK, Khanal B. Serum procalcitonin in bacterial & non-bacterial meningitis in children. BMC Pediatr. 2018; 18(1):342.
Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr. 1996;128:570-3.
Alkholi UM, Al-monem NA, El-Azim AAA, Sultan MH. Serum Procalcitonin in viral and bacterial meningitis. J Glob Infect Dis. 2011;3(1):14-8.
Nargis W, Ibrahim M, Ahamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4(3): 195-9.
Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less?. Swiss Med Wkly. 2005;135:451-60.
Meisner M. Update on Procalcitonin measurements. Ann Lab Med. 2014;34:263-73.
Viallon A. Guyomarc’h P, Guyomarc’h S, tardy B, Robert F, Marjollet O, et al. Decrease of serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care. 2005;9:R344-50.
